QuidelOrtho Fortifies Leadership with Strategic Appointment of Erich Wolff

QuidelOrtho, a global leader in vitro diagnostics, has announced a significant strategic appointment, welcoming Erich Wolff as its new Executive Vice President, Strategy & Corporate Development. This pivotal role, effective June 24, will see Mr. Wolff directly reporting to Michael Wilson, President and Chief Executive Officer, underscoring the company's commitment to accelerating its strategic growth and market expansion.

In his expansive new capacity, Mr.

Wolff will spearhead QuidelOrtho's global strategy, corporate development initiatives, mergers and acquisitions (M&A), and crucial strategic partnerships. His mandate is clear: to identify and seize opportunities that will further solidify QuidelOrtho's position as an innovation powerhouse in the diagnostic healthcare landscape, driving both organic and inorganic growth trajectories.

Mr.

Wolff brings an impressive quarter-century of experience, deeply rooted in the healthcare, diagnostics, and life sciences sectors. He joins QuidelOrtho from Danaher Corporation, where he served as Senior Vice President and Global Head of Corporate Development, playing a crucial role in shaping their strategic portfolio through numerous high-impact transactions.

His distinguished career also includes significant tenures at top-tier consulting firms such as PwC, L.E.K. Consulting, and IMS Health (now IQVIA), where he honed his expertise in strategic advisory and M&A. Academically, he holds a Bachelor of Arts degree from Princeton University and a Master of Business Administration from the Wharton School of the University of Pennsylvania.

Michael Wilson, QuidelOrtho’s President and CEO, expressed immense enthusiasm about the new appointment, stating, “Erich’s exceptional track record in corporate strategy and development, coupled with his deep industry knowledge, makes him an invaluable addition to our leadership team.

His strategic acumen will be instrumental as we continue to evolve our business, expand into new markets, and enhance our product portfolio to meet the evolving needs of global healthcare. We are confident that Erich will significantly contribute to our mission of advancing diagnostics to improve lives.”

This strategic hire underscores QuidelOrtho’s relentless pursuit of innovation and market leadership, reinforcing its capabilities to navigate complex global healthcare dynamics and deliver cutting-edge diagnostic solutions worldwide.